337.05
price up icon0.06%   +0.10
 
loading
Stryker Corp. stock is currently priced at $337.05, with a 24-hour trading volume of 279.97K. It has seen a +0.06% increased in the last 24 hours and a -3.72% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $336.1 pivot point. If it approaches the $338.9 resistance level, significant changes may occur.
Previous Close:
$337.15
Open:
$335.19
24h Volume:
279.97K
Market Cap:
$128.28B
Revenue:
$20.50B
Net Income/Loss:
$3.17B
P/E Ratio:
50.01
EPS:
6.74
Net Cash Flow:
$3.14B
1W Performance:
+3.66%
1M Performance:
-3.72%
6M Performance:
+30.46%
1Y Performance:
+12.90%
1D Range:
Value
$334.44
$337.90
52W Range:
Value
$249.98
$361.41

Stryker Corp. Stock (SYK) Company Profile

Name
Name
Stryker Corp.
Name
Phone
269-385-2600
Name
Address
2825 Airview Boulevard, Kalamazoo, MI
Name
Employee
33,000
Name
Twitter
Name
Next Earnings Date
2024-05-09
Name
Latest SEC Filings
Name
SYK's Discussions on Twitter

Stryker Corp. Stock (SYK) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-31-24 Upgrade Canaccord Genuity Hold → Buy
Oct-20-23 Initiated ROTH MKM Buy
Sep-05-23 Upgrade BofA Securities Neutral → Buy
Mar-29-23 Initiated UBS Neutral
Jan-25-23 Initiated KeyBanc Capital Markets Sector Weight
Jan-09-23 Upgrade RBC Capital Mkts Sector Perform → Outperform
Nov-01-22 Downgrade Canaccord Genuity Buy → Hold
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-28-22 Upgrade Edward Jones Hold → Buy
Jul-21-22 Downgrade Deutsche Bank Buy → Hold
Jul-11-22 Downgrade BofA Securities Buy → Neutral
Apr-13-22 Initiated Truist Hold
Mar-16-22 Upgrade Bernstein Mkt Perform → Outperform
Mar-15-22 Resumed Evercore ISI Outperform
Mar-02-22 Resumed BofA Securities Buy
Jan-07-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-04-22 Upgrade Piper Sandler Neutral → Overweight
Dec-10-21 Initiated RBC Capital Mkts Sector Perform
Dec-07-21 Initiated Loop Capital Buy
Sep-14-21 Resumed Raymond James Mkt Perform
Jul-28-21 Upgrade Northland Capital Market Perform → Outperform
Jun-01-21 Upgrade Evercore ISI In-line → Outperform
May-25-21 Initiated Barclays Underweight
Oct-06-20 Initiated Northland Capital Market Perform
Sep-11-20 Initiated Wolfe Research Peer Perform
Apr-13-20 Downgrade Barclays Equal Weight → Underweight
Apr-01-20 Downgrade Goldman Buy → Sell
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Buy
Jan-08-20 Initiated SunTrust Hold
Jan-07-20 Downgrade Piper Jaffray Overweight → Neutral
Jan-07-20 Downgrade Piper Sandler Overweight → Neutral
Dec-30-19 Reiterated BTIG Research Buy
Nov-05-19 Downgrade Barclays Overweight → Equal Weight
Oct-30-19 Reiterated BofA/Merrill Buy
Jul-02-19 Downgrade Evercore ISI Outperform → In-line
Jan-30-19 Reiterated Canaccord Genuity Buy
Jan-03-19 Initiated Deutsche Bank Buy
Jan-02-19 Upgrade Evercore ISI In-line → Outperform
Oct-16-18 Initiated Barclays Overweight
Aug-16-18 Initiated BTIG Research Buy
Jun-27-18 Initiated Bernstein Mkt Perform
Apr-27-18 Reiterated Stifel Buy
View All

Stryker Corp. Stock (SYK) Financials Data

Stryker Corp. (SYK) Revenue 2024

SYK reported a revenue (TTM) of $20.50 billion for the quarter ending December 31, 2023, a +11.11% rise year-over-year.
loading

Stryker Corp. (SYK) Net Income 2024

SYK net income (TTM) was $3.17 billion for the quarter ending December 31, 2023, a +34.22% increase year-over-year.
loading

Stryker Corp. (SYK) Cash Flow 2024

SYK recorded a free cash flow (TTM) of $3.14 billion for the quarter ending December 31, 2023, a +54.03% increase year-over-year.
loading

Stryker Corp. (SYK) Earnings per Share 2024

SYK earnings per share (TTM) was $8.25 for the quarter ending December 31, 2023, a +33.71% growth year-over-year.
loading

Stryker Corp. Stock (SYK) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Stiles Spencer S
Group President
Mar 21 '24
Option Exercise
0.00
203
0
55,602
Pierce James Andrew
Group President
Mar 21 '24
Option Exercise
0.00
203
0
60,664
Menon Viju
Group President
Mar 21 '24
Option Exercise
0.00
158
0
13,762
Lobo Kevin
Chair and CEO
Mar 21 '24
Option Exercise
0.00
905
0
119,719
Fletcher Robert S
VP, Chief Legal Officer
Mar 21 '24
Option Exercise
0.00
120
0
13,143
Fink M Kathryn
VP, Chief HR Officer
Mar 21 '24
Option Exercise
0.00
83
0
13,710
Boehnlein Glenn S
VP, Chief Financial Officer
Mar 21 '24
Option Exercise
0.00
256
0
31,152
Becker Yin C
VP, Chief Corp Affairs Officer
Mar 21 '24
Option Exercise
0.00
36
0
29,898
Berry William E Jr
VP, Chief Accounting Officer
Mar 08 '24
Option Exercise
154.14
1,480
228,127
5,155
Berry William E Jr
VP, Chief Accounting Officer
Mar 07 '24
Option Exercise
108.30
17,660
1,912,588
21,335
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 85 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
medical_devices BSX
$73.22
price down icon 0.08%
medical_devices MDT
$79.16
price down icon 0.11%
medical_devices ABT
$107.42
price up icon 0.51%
$128.94
price down icon 6.88%
medical_devices EW
$86.90
price down icon 1.20%
Cap:     |  Volume (24h):